Literature DB >> 22821177

Treatment of tobacco dependence in people with mental health and addictive disorders.

Kristen M Mackowick1, Marie-Josee Lynch, Andrea H Weinberger, Tony P George.   

Abstract

People with mental health and addictive disorders (MHADs) have higher rates of cigarette smoking, and less success in quitting smoking compared with the general population. Moreover, tobacco-related medical illness may be the leading cause of death in the MHAD population. We discuss the scope of this comorbidity, and approaches to the treatment of tobacco dependence in people with MHAD, including schizophrenia, mood disorders, anxiety disorders, and alcohol and substance use disorders. Finally, at the level of health systems, we emphasize the importance of integrated treatment of tobacco dependence in MHADs.

Entities:  

Mesh:

Year:  2012        PMID: 22821177      PMCID: PMC3722553          DOI: 10.1007/s11920-012-0299-2

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  74 in total

1.  Simultaneous versus delayed treatment of tobacco dependence in alcohol-dependent outpatients.

Authors:  G Nieva; L L Ortega; S Mondon; M Ballbè; A Gual
Journal:  Eur Addict Res       Date:  2010-09-25       Impact factor: 3.015

2.  Exacerbation of schizophrenia by varenicline.

Authors:  Robert Freedman
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

3.  Response to nicotine dependence treatment in smokers with current and past alcohol problems.

Authors:  J T Hays; D R Schroeder; K P Offord; I T Croghan; C A Patten; R D Hurt; D E Jorenby; M C Fiore
Journal:  Ann Behav Med       Date:  1999

4.  Differences in smoking expectancies in smokers with and without a history of major depression.

Authors:  Andrea H Weinberger; Tony P George; Sherry A McKee
Journal:  Addict Behav       Date:  2010-12-28       Impact factor: 3.913

Review 5.  A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.

Authors:  Victoria C Wing; Caroline E Wass; Debra W Soh; Tony P George
Journal:  Ann N Y Acad Sci       Date:  2011-11-30       Impact factor: 5.691

6.  Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.

Authors:  Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori
Journal:  JAMA       Date:  2010-12-08       Impact factor: 56.272

7.  A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Authors:  Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George
Journal:  J Clin Psychiatry       Date:  2012-05       Impact factor: 4.384

8.  The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study.

Authors:  James Poling; Bruce Rounsaville; Kishorchandra Gonsai; Kevin Severino; Mehmet Sofuoglu
Journal:  Am J Addict       Date:  2010 Sep-Oct

9.  A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.

Authors:  Amanda Baker; Robyn Richmond; Melanie Haile; Terry J Lewin; Vaughan J Carr; Rachel L Taylor; Sylvia Jansons; Kay Wilhelm
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

10.  A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder.

Authors:  Andrea H Weinberger; Jennifer C Vessicchio; Kristi A Sacco; Cerissa L Creeden; K N Roy Chengappa; Tony P George
Journal:  J Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.153

View more
  20 in total

1.  Evaluation of Community-Based Cessation Programs: How Do Smokers with Behavioral Health Conditions Fare?

Authors:  Clare Meernik; Anna McCullough; Leah Ranney; Barbara Walsh; Adam O Goldstein
Journal:  Community Ment Health J       Date:  2017-08-02

2.  Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.

Authors:  Karolina Kozak; Tony P George
Journal:  Expert Opin Pharmacother       Date:  2020-02-03       Impact factor: 3.889

3.  A Post-Discharge Smoking-Cessation Intervention for Hospital Patients: Helping Hand 2 Randomized Clinical Trial.

Authors:  Nancy A Rigotti; Hilary A Tindle; Susan Regan; Douglas E Levy; Yuchiao Chang; Kelly M Carpenter; Elyse R Park; Jennifer H K Kelley; Joanna M Streck; Zachary Z Reid; Thomas Ylioja; Michele Reyen; Daniel E Singer
Journal:  Am J Prev Med       Date:  2016-10       Impact factor: 5.043

4.  Comparison of cigarette smoking knowledge, attitudes, and practices among staff in perinatal and other substance abuse treatment settings.

Authors:  Tonya Miller-Thomas; Jeannie-Marie S Leoutsakos; Mishka Terplan; Emily P Brigham; Margaret S Chisolm
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

5.  Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.

Authors:  Can Peng; Clare Stokes; Yann S Mineur; Marina R Picciotto; Chengju Tian; Christoph Eibl; Isabelle Tomassoli; Daniela Guendisch; Roger L Papke
Journal:  J Pharmacol Exp Ther       Date:  2013-08-19       Impact factor: 4.030

6.  Schizophrenia--time to commit to policy change.

Authors:  W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff
Journal:  Schizophr Bull       Date:  2014-04       Impact factor: 9.306

7.  Analyzing excess mortality from cancer among individuals with mental illness.

Authors:  Jackson S Musuuza; Marion E Sherman; Kraig J Knudsen; Helen Anne Sweeney; Carl V Tyler; Siran M Koroukian
Journal:  Cancer       Date:  2013-04-12       Impact factor: 6.860

8.  Culturally-Tailored Smoking Cessation for Adult American Indian Smokers: A Clinical Trial.

Authors:  Stevens S Smith; Leah M Rouse; Mark Caskey; Jodi Fossum; Rick Strickland; J Kevin Culhane; Jerry Waukau
Journal:  Couns Psychol       Date:  2014-07-17

9.  The Epidemiology of DSM-5 Nicotine Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  S Patricia Chou; Risë B Goldstein; Sharon M Smith; Boji Huang; W June Ruan; Haitao Zhang; Jeesun Jung; Tulshi D Saha; Roger P Pickering; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

10.  E-cigarette Use in Veterans Seeking Mental Health and/or Substance Use Services.

Authors:  Kathryn Hefner; Robert Rosenheck; Jeremy Merrel; Marcedes Coffman; Gerry Valentine; Mehmet Sofuoglu
Journal:  J Dual Diagn       Date:  2016-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.